No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
438 |
4. Check minimum number of eventsNone |
438 |
5. Include endpointsNone |
438 |
6. Filter based on genotype QC (FinnGen only) |
426 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Measles
based on the number of shared cases.
Similar with more cases:
- Viral infections characterized by skin and mucous membrane lesions
- Viral infections characterized by skin and mucous membrane lesions
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4026 | 1752 | 2266 |
| Only index persons | 3751 | 1644 | 2107 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.05 | 0.06 |
| Only index persons | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 6.89 | 6.79 | 6.96 |
| Only index persons | 6.86 | 6.74 | 6.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 426 | 244 | 182 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.08 |
| Median age at first event (years) | 8.19 | 8.38 | 7.93 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 438
- Matched controls
- 4380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
05599
ICD-8 Finland
Measles, Non definita
+∞
272.3
232
*
05597
ICD-8 Finland
Measles, Suspecta
+∞
155.8
140
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
9.6
53.7
68
82
48609
ICD-8 Finland
Pneumonia, unspecified
10.5
31.6
36
37
0559X
ICD-9 Finland
Measles without mention of complication
+∞
19.9
19
*
48509
ICD-8 Finland
Bronchopneumonia, unspecified
7.8
19.7
28
38
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
4.1
19.3
58
158
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
4.3
16.5
45
114
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
5.5
15.1
30
58
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
5.6
12.4
24
45
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.5
12.1
23
23
B05.9
ICD-10 Finland
Measles without complication
+∞
11.5
11
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.4
10.5
84
397
A10AB05
ATC
insulin aspart; parenteral
3.3
10.1
40
131
05209
ICD-8 Finland
Chickenpox, Unspecified
+∞
9.4
9
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
5.2
9.2
19
38
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
4.4
9.0
23
55
A10AE04
ATC
insulin glargine; parenteral
2.9
8.5
41
151
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
14.8
8.2
13
9
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
8.2
95
519
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.4
8.0
20
47
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
8.0
96
532
S01AD03
ATC
aciclovir; ophthalmic
4.4
7.5
19
45
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
81.4
7.4
8
*
T89
ICPC
Diabetes insulin dependent
3.2
7.4
29
94
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
7.3
42
170
T90
ICPC
Diabetes non-insulin dependent
2.0
6.9
79
429
SPAT1310
SPAT
Counselling related to known health issue
1.8
6.7
115
713
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
6.6
162
1115
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.5
6.5
22
65
H02AB06
ATC
prednisolone; systemic
1.7
6.4
203
1491
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
6.4
76
417
A03FA02
ATC
cisapride; oral, rectal
2.9
6.4
29
103
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.1
52
252
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
144
843
2.06
10.61
3.5
2.9
8.35
8.95
mmol/l
0.82
123
750
111
602
2.13
9.94
2.4
2.1
2.97
2.88
mg/l
0.19
96
521
131
781
1.97
8.94
4.5
3.5
8.93
5.35
mg/mmol
0.49
87
491
155
1035
1.77
7.13
2.0
1.7
97.48
97.52
pmol/l
0.00
95
596
211
1559
1.68
6.60
3.4
2.7
130.78
104.40
ug/l
0.92
198
1488
145
979
1.72
6.27
2.7
3.4
2.34
2.35
mmol/l
0.17
135
908
123
795
1.76
6.20
1.7
1.7
0.63
0.77
mg/l
0.58
99
600
68
371
1.99
5.81
2.0
1.6
1213.67
1150.16
nmol/l
0.27
60
301
169
1216
1.63
5.62
5.9
4.9
36.26
37.19
g/l
1.44
159
1166
64
347
1.99
5.56
3.7
2.5
25.71
24.71
%
0.17
57
298
165
1211
1.58
4.91
9.9
8.6
1.16
1.11
inr
0.45
65
376
66
383
1.85
4.68
3.5
2.4
2.37
2.46
g/l
0.72
60
357
21
75
2.89
4.62
1.5
2.2
1.44
1.43
g/l
0.02
21
66
88
562
1.71
4.51
2.5
2.9
778.16
679.01
ng/l
0.09
70
450
84
552
1.65
3.84
1.7
1.4
18.98
22.16
nmol/l
1.03
77
498
12
29
4.22
3.73
1.6
1.2
—
—
—
0
0
170
1321
1.47
3.63
2.8
2.3
70.41
72.69
nmol/l
0.52
159
1246
217
1769
1.45
3.60
5.4
4.5
6.90
6.53
mmol/l
1.31
206
1677
109
784
1.52
3.37
3.8
3.1
0.00
0.00
estimate
0.50
41
277
69
448
1.64
3.30
2.5
2.8
2.42
2.42
mmol/l
0.12
62
399
102
728
1.52
3.26
1.3
1.3
37.33
24.66
iu/ml
0.53
28
272
13
40
3.32
3.16
2.5
2.2
17.39
16.63
%
—
8
25
56
348
1.70
3.16
1.9
2.2
320.12
366.36
nmol/l
1.50
50
328
129
976
1.46
3.08
3.8
2.7
—
—
—
0
0
21
96
2.25
2.88
1.4
1.3
—
—
—
0
0
120
908
1.44
2.84
2.6
2.0
343.32
4034.07
umol/l
2.17
109
844
13
47
2.82
2.84
4.0
3.1
—
1228.00
—
0
5
43
257
1.75
2.80
3.6
2.9
—
—
—
0
0
292
2581
1.39
2.71
4.7
3.7
10.64
8.62
mm/h
2.33
275
2460
34
193
1.83
2.63
1.9
1.6
—
—
—
0
0
131
1022
1.40
2.59
4.0
2.6
54.51
57.15
u/l
0.40
125
974
16
69
2.37
2.51
1.5
1.2
—
—
—
0
0
7
16
4.43
2.48
3.1
2.9
673.14
761.69
u/ml
—
7
16
94
699
1.44
2.42
1.3
1.2
3.37
11.32
u/ml
1.61
36
335
11
41
2.73
2.22
1.2
1.2
—
—
—
0
0
57
393
1.52
2.14
2.9
2.3
6.94
6.81
umol/l
0.02
50
347
197
1682
1.31
2.08
6.0
5.8
9.51
10.79
umol/l
2.23
192
1621
6
15
4.04
2.04
3.8
3.3
35766.67
34400.00
ug/l
—
6
15
11
44
2.54
2.02
1.1
1.2
—
—
—
0
0
39
251
1.61
1.98
3.1
3.9
4.51
4.58
pmol/l
0.17
26
220
8
28
2.89
1.87
1.0
1.0
—
—
—
0
0
11
46
2.43
1.86
1.1
1.2
—
—
—
0
0
5
12
4.20
1.83
1.4
1.5
168.78
101.17
nmol/24h
—
5
12
83
636
1.38
1.80
1.7
2.0
1.38
1.37
%
0.10
76
590
75
565
1.40
1.80
1.8
1.6
486.06
14175180.40
pmol/l
0.50
66
515
24
139
1.77
1.79
1.9
1.4
—
—
—
0
0
11
47
2.37
1.79
2.5
1.9
7.93
8.36
kpa
0.54
11
47
186
1600
1.28
1.79
3.6
2.8
0.00
0.01
estimate
0.50
40
266
185
1593
1.28
1.76
4.7
3.8
0.00
0.00
estimate
0.50
46
282
35
227
1.59
1.74
4.5
3.5
2.82
2.01
mmol/l
0.64
30
197
134
1108
1.30
1.74
3.2
2.7
27.64
33.20
ng/l
0.18
70
547
21
119
1.80
1.69
1.8
1.6
1.72
1505.04
u/l
—
5
36
104
834
1.32
1.68
1.3
1.3
1.13
2.17
u/ml
0.74
33
247
113
918
1.31
1.66
2.5
2.0
240.89
170.40
u/l
0.28
103
882
166
1419
1.27
1.65
3.1
2.3
—
—
—
0
0
6
20
3.03
1.58
1.0
1.1
—
—
—
0
0
26
161
1.65
1.56
3.0
2.3
250.89
79.17
ng/l
1.02
20
136
48
343
1.45
1.55
5.8
5.4
—
—
—
0
0
47
335
1.45
1.54
4.3
3.5
29.34
30.48
%
0.27
35
258
224
1996
1.25
1.53
10.6
9.3
4.24
3.93
e9/l
1.11
201
1773
7
27
2.62
1.52
1.1
2.0
—
—
—
0
0
6
21
2.88
1.51
1.0
1.6
—
—
—
0
0
31
204
1.56
1.47
1.7
1.7
—
—
—
0
0
182
1592
1.25
1.45
3.6
2.8
0.00
0.00
estimate
0.50
47
291
6
22
2.75
1.44
2.3
2.5
—
—
—
0
0
90
724
1.31
1.42
3.6
2.5
0.18
0.30
e6/l
0.67
73
544
341
3206
1.29
1.40
18.1
12.8
14.58
14.22
%
0.61
335
3168
15
82
1.86
1.37
1.0
1.3
—
—
—
0
0
141
1207
1.25
1.35
8.7
5.9
1.21
1.21
mmol/l
0.23
132
1112
194
1720
1.23
1.34
7.5
6.0
27.92
29.13
%
1.01
187
1641
13
69
1.91
1.30
3.2
4.2
3.95
4.26
e9/l
0.33
13
69
13
69
1.91
1.30
3.1
5.0
56.54
58.30
%
0.24
13
69
40
287
1.43
1.29
4.2
2.9
37.66
51.19
u/l
0.39
35
248
43
313
1.41
1.28
7.2
7.6
104.02
104.34
mmol/l
0.16
43
313
191
1701
1.22
1.24
7.3
5.8
58.20
56.54
%
1.42
186
1621
106
887
1.26
1.23
1.9
1.7
1.49
1.52
mmol/l
0.15
87
784
55
421
1.35
1.23
1.8
1.7
—
—
—
0
0
10
49
2.07
1.23
1.2
1.1
—
—
—
0
0
36
258
1.43
1.18
2.3
1.6
—
—
—
0
0
399
3856
1.39
1.16
4.6
4.1
2.84
3.02
mmol/l
3.71
374
3707
354
3367
1.27
1.16
6.2
4.3
41.44
38.41
mmol/mol
4.77
337
3224
13
72
1.83
1.16
2.1
1.8
—
—
—
0
0
8
39
2.07
1.16
1.3
1.9
—
—
—
0
0
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
280
2604
1.21
1.12
8.9
6.9
79.50
75.51
u/l
0.84
271
2492
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
50
384
1.34
1.10
2.3
1.7
—
—
—
0
0
24
161
1.52
1.09
1.6
1.7
—
—
—
0
0
7
32
2.21
1.08
1.1
1.2
—
80.00
—
0
5
395
3821
1.34
1.05
4.4
3.9
4.74
4.93
mmol/l
3.05
371
3690
18
114
1.60
1.04
1.2
1.1
—
—
—
0
0
60
478
1.30
1.04
2.0
1.8
—
—
—
0
0
146
1286
1.20
1.03
3.5
2.8
—
—
—
0
0
15
91
1.67
1.02
1.1
1.1
0.70
2.67
u/ml
—
8
44
385
3715
1.30
1.01
4.0
3.5
1.43
1.36
mmol/l
0.69
362
3558
11
61
1.82
0.99
2.0
1.5
—
113.18
—
0
11
5
23
2.19
0.98
1.8
1.7
—
—
—
0
0
298
2804
1.20
0.98
4.2
4.0
14.56
14.33
pmol/l
1.03
282
2670
50
393
1.31
0.96
3.1
2.3
1.71
2.51
e6/l
0.58
27
195
346
3304
1.22
0.96
4.9
4.5
1.70
2.14
mu/l
0.68
323
3158
380
3667
1.27
0.95
16.2
10.8
139.40
139.74
mmol/l
2.18
369
3602
9
52
1.75
0.93
1.0
1.0
1.35
1.48
g/l
—
9
46
80
673
1.23
0.89
2.7
2.9
1.02
1.02
kg/l
0.00
11
81
393
3814
1.30
0.88
4.4
3.8
1.41
1.44
mmol/l
1.03
370
3668
35
265
1.35
0.87
2.3
1.6
—
—
—
0
0
65
537
1.25
0.86
3.7
3.2
121.37
262.81
ng/l
0.63
40
345
13
80
1.64
0.85
2.7
2.1
350.03
320.81
ug/l
0.04
13
71
8
45
1.79
0.84
2.6
1.5
—
—
—
0
0
16
105
1.54
0.83
1.0
1.1
—
—
—
0
0
36
277
1.33
0.82
5.7
10.5
1.19
1.21
mmol/l
0.01
30
218
6
32
1.89
0.82
1.2
1.7
—
—
—
0
0
52
421
1.27
0.82
2.6
2.2
0.90
1.06
e6/l
0.21
30
224
12
187
0.63
0.80
1.6
1.5
—
—
—
0
0
16
106
1.53
0.80
1.0
1.1
—
—
—
0
0
11
66
1.68
0.79
1.3
1.2
—
—
—
0
0
9
53
1.71
0.76
1.9
1.1
—
—
—
0
0
9
53
1.71
0.76
1.9
1.1
—
—
—
0
0
5
24
2.10
0.74
1.0
1.0
—
—
—
0
0
362
3497
1.20
0.74
13.1
9.0
90.65
89.76
ml/min/173m2
0.42
316
2959
9
55
1.65
0.74
1.7
2.4
—
4.24
—
0
5
7
38
1.86
0.74
1.1
1.8
1.23
1.42
nmol/l
—
7
32
5
25
2.01
0.73
1.2
1.1
—
—
—
0
0
78
672
1.20
0.70
3.7
2.1
—
—
—
0
0
150
1365
1.15
0.69
9.9
6.7
1.21
1.21
mmol/l
0.46
125
1173
5
28
1.79
0.66
1.4
1.5
—
—
—
0
0
5
28
1.79
0.66
1.4
1.5
—
—
—
0
0
18
129
1.41
0.64
1.4
1.2
—
—
—
0
0
5
30
1.67
0.61
2.0
1.1
—
—
—
0
0
91
807
1.16
0.60
1.5
1.5
—
—
—
0
0
8
53
1.52
0.58
1.4
1.5
—
—
—
0
0
378
3685
1.19
0.58
16.7
10.8
3.94
3.95
mmol/l
0.13
365
3611
15
106
1.43
0.58
1.9
1.4
212.41
318.22
ug/g
—
8
57
6
37
1.63
0.55
1.2
1.4
—
—
—
0
0
9
60
1.51
0.54
1.2
1.8
—
—
—
0
0
9
60
1.51
0.54
1.2
1.8
—
—
—
0
0
11
74
1.50
0.54
1.1
1.2
—
—
—
0
0
15
108
1.40
0.53
1.3
1.5
0.26
0.24
g/l
0.21
15
101
6
39
1.55
0.53
1.3
1.7
—
—
—
0
0
6
39
1.55
0.53
1.3
1.7
—
—
—
0
0
13
93
1.41
0.48
1.5
1.5
—
—
—
0
0
7
47
1.50
0.47
1.9
2.3
—
—
—
0
0
15
111
1.36
0.47
1.3
1.5
1.25
1.23
g/l
0.09
15
103
363
3543
1.14
0.46
4.3
3.7
6.15
5.77
mmol/l
3.49
330
3373
374
3661
1.15
0.44
16.5
10.6
20.72
19.82
mg/l
0.19
301
2820
8
57
1.41
0.42
2.1
1.4
7313.88
9568.49
e6/l
—
8
37
0
15
0.00
0.41
0.0
1.0
—
109.10
—
0
10
0
15
0.00
0.41
0.0
1.0
—
98.00
—
0
10
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.0
—
128.67
—
0
15
16
123
1.31
0.41
2.2
3.0
49.57
52.89
%
0.28
16
123
72
797
0.88
0.40
2.7
2.8
17.94
21.83
%
2.33
24
225
5
35
1.43
0.39
1.8
2.0
1032.40
673.40
e6/l
—
5
35
18
142
1.28
0.39
1.6
1.3
33.00
230.67
miu/ml
—
6
73
30
252
1.20
0.39
2.3
2.2
72.33
77.79
ml/min/173m2
0.22
12
95
5
37
1.36
0.37
1.2
1.5
—
—
—
0
0
23
189
1.23
0.37
1.7
1.6
—
—
—
0
0
74
675
1.12
0.34
1.4
1.4
—
—
—
0
0
27
229
1.19
0.33
3.8
4.4
5.33
13.65
ug/l
0.57
15
174
6
47
1.28
0.32
1.2
1.3
130.60
180.61
pmol/l
—
6
47
18
147
1.23
0.31
7.8
11.6
1.35
1.66
%
1.00
18
147
18
147
1.23
0.31
8.5
11.7
0.84
0.73
%
0.53
18
147
416
4195
0.83
0.29
22.6
15.4
41.36
41.50
%
0.23
402
4029
18
149
1.22
0.28
8.5
11.7
94.01
93.37
%
0.20
18
149
301
2940
1.08
0.27
3.4
3.0
49.88
46.75
u/l
0.23
288
2854
14
115
1.22
0.24
2.8
1.6
—
—
—
0
0
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
5
41
1.22
0.22
2.0
1.4
1.38
1.53
g/l
—
5
41
5
41
1.22
0.22
2.0
1.4
0.87
1.01
g/l
—
5
41
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
9.28
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
17
145
1.18
0.21
1.1
1.3
12.64
10.37
u/l
0.17
11
124
418
4205
0.87
0.19
22.5
15.5
138.76
140.04
g/l
1.05
413
4169
304
2990
1.05
0.18
3.3
3.4
—
—
—
0
0
16
138
1.17
0.17
3.3
2.4
0.63
0.70
%
0.35
16
138
418
4204
0.87
0.17
22.4
15.4
4.61
4.64
e12/l
0.75
412
4133
39
359
1.09
0.17
2.3
2.3
12.83
14.07
nmol/l
0.55
34
342
46
427
1.09
0.17
1.3
1.3
30.97
31.52
iu/l
0.04
39
380
8
68
1.18
0.16
3.3
2.4
—
—
—
0
0
26
287
0.90
0.16
1.2
1.2
144.77
154.75
iu/ml
0.05
13
126
418
4202
0.89
0.15
22.4
15.4
265.91
259.89
e9/l
1.05
412
4133
7
66
1.06
0.08
6.1
5.8
386.29
371.18
umol/l
—
7
57
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
8
78
1.03
0.07
1.1
1.3
—
—
—
0
0
12
132
0.91
0.06
1.6
2.1
—
—
—
0
0
402
4004
1.05
0.06
11.3
8.8
29.73
29.75
u/l
0.00
392
3936
15
161
0.93
0.05
1.5
1.4
—
—
—
0
0
13
140
0.93
0.04
3.2
1.8
199.85
208.78
pmol/l
0.12
13
130
21
219
0.96
0.03
1.5
1.4
—
—
—
0
0
61
621
0.98
0.03
1.6
1.8
—
—
—
0
0
13
122
1.07
0.02
2.5
1.7
—
—
—
0
0
100
990
1.01
0.02
2.5
2.8
1.64
1.35
ug/l
0.72
91
918
60
609
0.98
0.02
2.2
2.2
0.62
0.61
ug/l
0.06
29
275
10
101
0.99
0.00
1.9
1.7
—
—
—
0
0
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
5
59
0.85
0.00
1.0
1.2
7.98
7.64
mmol/l
—
5
53
5
52
0.96
0.00
1.2
1.6
—
—
—
0
0
6
63
0.95
-0.00
1.5
1.1
—
—
—
0
0
22
220
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
106.67
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
69
1.01
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
1.18
—
0
9
5
54
0.93
-0.00
1.6
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
74
0.95
-0.00
1.3
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
92
0.98
-0.00
2.0
1.5
—
—
—
0
0
7
72
0.97
-0.00
1.3
1.1
—
15.47
—
0
6
0
7
0.00
-0.00
0.0
3.4
—
0.43
—
0
7
0
7
0.00
-0.00
0.0
4.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_MEASLES and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_MEASLES.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_MEASLES – Measles
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data